United States Human Vaccines Market Report 2017

December 2017 | 112 pages | ID: U0A92ED393CEN
QYResearch

Abstracts

In this report, the United States Human Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Human Vaccines in these regions, from 2012 to 2022 (forecast).

United States Human Vaccines market competition by top manufacturers/players, with Human Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• AstraZeneca
• Bavarian Nordic
• Bharat Biotech
• CSL Limited
• Emergent BioSolutions, Inc.
• GlaxoSmithKline plc
• Johnson & Johnson
• Merck & Co., Inc.
• Mymetics
• Novartis AG
• Pfizer, Inc.
• Sanofi
• Shenzhen Kangtai Biological Products Co., Ltd.
• Takeda Pharmaceutical Company Limited.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Pneumococcal
• Influenza
• Hepatitis
• HPV
• Meningococcal
• Rotavirus
• Measles
• Typhoid
• Combination

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Pediatrics
• Adolescents
• Adults
• Geriatrics

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Human Vaccines Market Report 2017

1 HUMAN VACCINES OVERVIEW

1.1 Product Overview and Scope of Human Vaccines
1.2 Classification of Human Vaccines by Product Category
  1.2.1 United States Human Vaccines Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Human Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Pneumococcal
  1.2.4 Influenza
  1.2.5 Hepatitis
  1.2.6 HPV
  1.2.7 Meningococcal
  1.2.8 Rotavirus
  1.2.9 Measles
  1.2.10 Typhoid
  1.2.11 Combination
1.3 United States Human Vaccines Market by Application/End Users
  1.3.1 United States Human Vaccines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Pediatrics
  1.3.3 Adolescents
  1.3.4 Adults
  1.3.5 Geriatrics
1.4 United States Human Vaccines Market by Region
  1.4.1 United States Human Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Human Vaccines Status and Prospect (2012-2022)
  1.4.3 Southwest Human Vaccines Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Human Vaccines Status and Prospect (2012-2022)
  1.4.5 New England Human Vaccines Status and Prospect (2012-2022)
  1.4.6 The South Human Vaccines Status and Prospect (2012-2022)
  1.4.7 The Midwest Human Vaccines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Human Vaccines (2012-2022)
  1.5.1 United States Human Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 United States Human Vaccines Revenue and Growth Rate (2012-2022)

2 UNITED STATES HUMAN VACCINES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Human Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Human Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Human Vaccines Average Price by Players/Suppliers (2012-2017)
2.4 United States Human Vaccines Market Competitive Situation and Trends
  2.4.1 United States Human Vaccines Market Concentration Rate
  2.4.2 United States Human Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Human Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HUMAN VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Human Vaccines Sales and Market Share by Region (2012-2017)
3.2 United States Human Vaccines Revenue and Market Share by Region (2012-2017)
3.3 United States Human Vaccines Price by Region (2012-2017)

4 UNITED STATES HUMAN VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Human Vaccines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Human Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States Human Vaccines Price by Type (2012-2017)
4.4 United States Human Vaccines Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HUMAN VACCINES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Human Vaccines Sales and Market Share by Application (2012-2017)
5.2 United States Human Vaccines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HUMAN VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AstraZeneca
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Vaccines Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AstraZeneca Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bavarian Nordic
  6.2.2 Human Vaccines Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bavarian Nordic Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bharat Biotech
  6.3.2 Human Vaccines Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bharat Biotech Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 CSL Limited
  6.4.2 Human Vaccines Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 CSL Limited Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Emergent BioSolutions, Inc.
  6.5.2 Human Vaccines Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Emergent BioSolutions, Inc. Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 GlaxoSmithKline plc
  6.6.2 Human Vaccines Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 GlaxoSmithKline plc Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Johnson & Johnson
  6.7.2 Human Vaccines Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Johnson & Johnson Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Merck & Co., Inc.
  6.8.2 Human Vaccines Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Merck & Co., Inc. Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Mymetics
  6.9.2 Human Vaccines Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Mymetics Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Novartis AG
  6.10.2 Human Vaccines Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Novartis AG Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Pfizer, Inc.
6.12 Sanofi
6.13 Shenzhen Kangtai Biological Products Co., Ltd.
6.14 Takeda Pharmaceutical Company Limited.

7 HUMAN VACCINES MANUFACTURING COST ANALYSIS

7.1 Human Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HUMAN VACCINES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Human Vaccines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Human Vaccines Sales Volume Forecast by Type (2017-2022)
11.3 United States Human Vaccines Sales Volume Forecast by Application (2017-2022)
11.4 United States Human Vaccines Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Human Vaccines
Figure United States Human Vaccines Market Size () by Type (2012-2022)
Figure United States Human Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Pneumococcal Product Picture
Figure Influenza Product Picture
Figure Hepatitis Product Picture
Figure HPV Product Picture
Figure Meningococcal Product Picture
Figure Rotavirus Product Picture
Figure Measles Product Picture
Figure Typhoid Product Picture
Figure Combination Product Picture
Figure United States Human Vaccines Market Size () by Application (2012-2022)
Figure United States Sales Market Share of Human Vaccines by Application in 2016
Figure Pediatrics Examples
Table Key Downstream Customer in Pediatrics
Figure Adolescents Examples
Table Key Downstream Customer in Adolescents
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Geriatrics Examples
Table Key Downstream Customer in Geriatrics
Figure United States Human Vaccines Market Size (Million USD) by Region (2012-2022)
Figure The West Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Vaccines Sales () and Growth Rate (2012-2022)
Figure United States Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Vaccines Market Major Players Product Sales Volume () (2012-2017)
Table United States Human Vaccines Sales () of Key Players/Suppliers (2012-2017)
Table United States Human Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Vaccines Sales Share by Players/Suppliers
Figure 2017 United States Human Vaccines Sales Share by Players/Suppliers
Figure United States Human Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Human Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Human Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Vaccines Revenue Share by Players/Suppliers
Figure 2017 United States Human Vaccines Revenue Share by Players/Suppliers
Table United States Market Human Vaccines Average Price () of Key Players/Suppliers (2012-2017)
Figure United States Market Human Vaccines Average Price () of Key Players/Suppliers in 2016
Figure United States Human Vaccines Market Share of Top 3 Players/Suppliers
Figure United States Human Vaccines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Human Vaccines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Human Vaccines Product Category
Table United States Human Vaccines Sales () by Region (2012-2017)
Table United States Human Vaccines Sales Share by Region (2012-2017)
Figure United States Human Vaccines Sales Share by Region (2012-2017)
Figure United States Human Vaccines Sales Market Share by Region in 2016
Table United States Human Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Human Vaccines Revenue Share by Region (2012-2017)
Figure United States Human Vaccines Revenue Market Share by Region (2012-2017)
Figure United States Human Vaccines Revenue Market Share by Region in 2016
Table United States Human Vaccines Price () by Region (2012-2017)
Table United States Human Vaccines Sales () by Type (2012-2017)
Table United States Human Vaccines Sales Share by Type (2012-2017)
Figure United States Human Vaccines Sales Share by Type (2012-2017)
Figure United States Human Vaccines Sales Market Share by Type in 2016
Table United States Human Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Human Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Human Vaccines by Type (2012-2017)
Figure Revenue Market Share of Human Vaccines by Type in 2016
Table United States Human Vaccines Price () by Types (2012-2017)
Figure United States Human Vaccines Sales Growth Rate by Type (2012-2017)
Table United States Human Vaccines Sales () by Application (2012-2017)
Table United States Human Vaccines Sales Market Share by Application (2012-2017)
Figure United States Human Vaccines Sales Market Share by Application (2012-2017)
Figure United States Human Vaccines Sales Market Share by Application in 2016
Table United States Human Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Human Vaccines Sales Growth Rate by Application (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure AstraZeneca Human Vaccines Sales Growth Rate (2012-2017)
Figure AstraZeneca Human Vaccines Sales Market Share in United States (2012-2017)
Figure AstraZeneca Human Vaccines Revenue Market Share in United States (2012-2017)
Table Bavarian Nordic Basic Information List
Table Bavarian Nordic Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Bavarian Nordic Human Vaccines Sales Growth Rate (2012-2017)
Figure Bavarian Nordic Human Vaccines Sales Market Share in United States (2012-2017)
Figure Bavarian Nordic Human Vaccines Revenue Market Share in United States (2012-2017)
Table Bharat Biotech Basic Information List
Table Bharat Biotech Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Bharat Biotech Human Vaccines Sales Growth Rate (2012-2017)
Figure Bharat Biotech Human Vaccines Sales Market Share in United States (2012-2017)
Figure Bharat Biotech Human Vaccines Revenue Market Share in United States (2012-2017)
Table CSL Limited Basic Information List
Table CSL Limited Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure CSL Limited Human Vaccines Sales Growth Rate (2012-2017)
Figure CSL Limited Human Vaccines Sales Market Share in United States (2012-2017)
Figure CSL Limited Human Vaccines Revenue Market Share in United States (2012-2017)
Table Emergent BioSolutions, Inc. Basic Information List
Table Emergent BioSolutions, Inc. Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Emergent BioSolutions, Inc. Human Vaccines Sales Growth Rate (2012-2017)
Figure Emergent BioSolutions, Inc. Human Vaccines Sales Market Share in United States (2012-2017)
Figure Emergent BioSolutions, Inc. Human Vaccines Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc Human Vaccines Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline plc Human Vaccines Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline plc Human Vaccines Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Johnson & Johnson Human Vaccines Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Human Vaccines Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Human Vaccines Revenue Market Share in United States (2012-2017)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Human Vaccines Sales Growth Rate (2012-2017)
Figure Merck & Co., Inc. Human Vaccines Sales Market Share in United States (2012-2017)
Figure Merck & Co., Inc. Human Vaccines Revenue Market Share in United States (2012-2017)
Table Mymetics Basic Information List
Table Mymetics Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Mymetics Human Vaccines Sales Growth Rate (2012-2017)
Figure Mymetics Human Vaccines Sales Market Share in United States (2012-2017)
Figure Mymetics Human Vaccines Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Novartis AG Human Vaccines Sales Growth Rate (2012-2017)
Figure Novartis AG Human Vaccines Sales Market Share in United States (2012-2017)
Figure Novartis AG Human Vaccines Revenue Market Share in United States (2012-2017)
Table Pfizer, Inc. Basic Information List
Table Sanofi Basic Information List
Table Shenzhen Kangtai Biological Products Co., Ltd. Basic Information List
Table Takeda Pharmaceutical Company Limited. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Vaccines
Figure Manufacturing Process Analysis of Human Vaccines
Figure Human Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Human Vaccines Major Players/Suppliers in 2016
Table Major Buyers of Human Vaccines
Table Distributors/Traders List
Figure United States Human Vaccines Sales Volume () and Growth Rate Forecast (2017-2022)
Figure United States Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Human Vaccines Price () Trend Forecast (2017-2022)
Table United States Human Vaccines Sales Volume () Forecast by Type (2017-2022)
Figure United States Human Vaccines Sales Volume () Forecast by Type (2017-2022)
Figure United States Human Vaccines Sales Volume () Forecast by Type in 2022
Table United States Human Vaccines Sales Volume () Forecast by Application (2017-2022)
Figure United States Human Vaccines Sales Volume () Forecast by Application (2017-2022)
Figure United States Human Vaccines Sales Volume () Forecast by Application in 2022
Table United States Human Vaccines Sales Volume () Forecast by Region (2017-2022)
Table United States Human Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Vaccines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources